We further found that the MPC1−/− cells significantly increased glycolysis and cell invasion, which is consistent with the negative correlation between MPC1 expression and patient survival rate [14, 50], indicating its tumor genetic role in prostate cancer. The gene discussed is MPC1; the disease is Familial prostate cancer.